194 related articles for article (PubMed ID: 28573630)
1. Evaluation of Medical Countermeasures Against Ebolaviruses in Nonhuman Primate Models.
Mire CE; Geisbert TW
Methods Mol Biol; 2017; 1628():293-307. PubMed ID: 28573630
[TBL] [Abstract][Full Text] [Related]
2. Animal models for ebolavirus countermeasures discovery: what defines a useful model?
Shurtleff AC; Bavari S
Expert Opin Drug Discov; 2015 Jul; 10(7):685-702. PubMed ID: 26004783
[TBL] [Abstract][Full Text] [Related]
3. Ebola virus vaccines - reality or fiction?
Mire CE; Geisbert TW; Feldmann H; Marzi A
Expert Rev Vaccines; 2016 Nov; 15(11):1421-1430. PubMed ID: 27078187
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Ebola Virus Countermeasures in Guinea Pigs.
Marzi A
Methods Mol Biol; 2017; 1628():283-291. PubMed ID: 28573629
[TBL] [Abstract][Full Text] [Related]
5. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.
Kroeker A; Griffin BD; Qiu X; Kobinger G
Methods Mol Biol; 2017; 1628():273-282. PubMed ID: 28573628
[TBL] [Abstract][Full Text] [Related]
6.
Woolsey C; Borisevich V; Agans KN; Fenton KA; Cross RW; Geisbert TW
mBio; 2021 Aug; 12(4):e0151721. PubMed ID: 34372693
[TBL] [Abstract][Full Text] [Related]
7. Vaccines against 'the other' Ebolavirus species.
Kozak RA; Kobinger GP
Expert Rev Vaccines; 2016 Sep; 15(9):1093-100. PubMed ID: 27010528
[TBL] [Abstract][Full Text] [Related]
8. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
Geisbert TW; Strong JE; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
[TBL] [Abstract][Full Text] [Related]
9. [Ebola vaccine and treatment].
Takada A
Uirusu; 2015; 65(1):61-70. PubMed ID: 26923959
[TBL] [Abstract][Full Text] [Related]
10. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.
Bornholdt ZA; Herbert AS; Mire CE; He S; Cross RW; Wec AZ; Abelson DM; Geisbert JB; James RM; Rahim MN; Zhu W; Borisevich V; Banadyga L; Gunn BM; Agans KN; Wirchnianski AS; Goodwin E; Tierney K; Shestowsky WS; Bohorov O; Bohorova N; Velasco J; Ailor E; Kim D; Pauly MH; Whaley KJ; Alter G; Walker LM; Chandran K; Zeitlin L; Qiu X; Geisbert TW; Dye JM
Cell Host Microbe; 2019 Jan; 25(1):49-58.e5. PubMed ID: 30629918
[TBL] [Abstract][Full Text] [Related]
11. Nonhuman Primate Models of Ebola Virus Disease.
Bennett RS; Huzella LM; Jahrling PB; Bollinger L; Olinger GG; Hensley LE
Curr Top Microbiol Immunol; 2017; 411():171-193. PubMed ID: 28643203
[TBL] [Abstract][Full Text] [Related]
12. Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.
Yamaoka S; Ebihara H
Virulence; 2021 Dec; 12(1):885-901. PubMed ID: 33734027
[TBL] [Abstract][Full Text] [Related]
13. Ebola virus vaccines: an overview of current approaches.
Marzi A; Feldmann H
Expert Rev Vaccines; 2014 Apr; 13(4):521-31. PubMed ID: 24575870
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop.
Mire CE; Geisbert TW
Trends Mol Med; 2017 Aug; 23(8):669-671. PubMed ID: 28697885
[TBL] [Abstract][Full Text] [Related]
15. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
Vu H; Shulenin S; Grolla A; Audet J; He S; Kobinger G; Unfer RC; Warfield KL; Aman MJ; Holtsberg FW
Antiviral Res; 2016 Feb; 126():55-61. PubMed ID: 26681387
[TBL] [Abstract][Full Text] [Related]
16. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
[TBL] [Abstract][Full Text] [Related]
17. Nonhuman primates as models for the discovery and development of ebolavirus therapeutics.
Shurtleff AC; Warren TK; Bavari S
Expert Opin Drug Discov; 2011 Mar; 6(3):233-50. PubMed ID: 22647202
[TBL] [Abstract][Full Text] [Related]
18. Towards a vaccine against Ebola virus.
Geisbert TW; Jahrling PB
Expert Rev Vaccines; 2003 Dec; 2(6):777-89. PubMed ID: 14711361
[TBL] [Abstract][Full Text] [Related]
19. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.
Smither SJ; Nelson M; Eastaugh L; Nunez A; Salguero FJ; Lever MS
J Infect Dis; 2015 Oct; 212 Suppl 2():S336-45. PubMed ID: 26209682
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Sudan Ebolavirus infection in ferrets.
Kroeker A; He S; de La Vega MA; Wong G; Embury-Hyatt C; Qiu X
Oncotarget; 2017 Jul; 8(28):46262-46272. PubMed ID: 28545034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
